Complete Filing Data
Adagio Medical Holdings, Inc. reported Stockholders Equity of $12.40 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Adagio Medical Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2023 |
|---|---|---|
| Net Income * | -$25.1M | -$36.6M |
| Operating Income Loss | -$21.9M | -$27.9M |
| Selling General And Administrative Expense | $10.6M | $11.5M |
| Research And Development Expense | $10.6M | $15.4M |
| Other Nonoperating Income Expense | $195.0K | -$20.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$100.0K | -$11.0K |
| Nonoperating Income Expense | -$3.2M | -$8.6M |
| Interest Expense Nonoperating | $2.9M | $1.7M |
| Cost Of Revenue | $684.0K | $1.3M |
| Comprehensive Income Net Of Tax | -$25.2M | -$36.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $300.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$10.1M | -$3.9M | -$7.7M | $3.6M | -$5.7M | -$8.0M | -$10.8M |
| Operating Income Loss | -$5.7M | -$4.7M | -$7.4M | -$4.4M | -$6.7M | -$8.8M | -$9.1M |
| Selling General And Administrative Expense | $2.9M | $2.4M | $3.5M | $2.9M | $3.4M | $4.8M | $4.5M |
| Research And Development Expense | $2.8M | $2.0M | $3.7M | $1.2M | $2.9M | $3.5M | $4.4M |
| Other Nonoperating Income Expense | $12.0K | $102.0K | -$46.0K | $72.0K | $5.0K | -$43.0K | -$123.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $4.0K | -$39.0K | -$61.0K | -$9.0K | $2.0K | $3.0K | $4.0K |
| Nonoperating Income Expense | -$4.4M | $770.0K | -$316.0K | $8.0M | $925.0K | $797.0K | -$1.7M |
| Interest Expense Nonoperating | $749.0K | $720.0K | $662.0K | $435.0K | $760.0K | $754.0K | $485.0K |
| Cost Of Revenue | $31.0K | $342.0K | $253.0K | $414.0K | $682.0K | $542.0K | $253.0K |
| Comprehensive Income Net Of Tax | -$10.1M | -$4.0M | -$7.8M | $3.6M | -$5.7M | -$8.0M | -$10.8M |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $132.0K | $254.0K | $26.0K | $41.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $12.4M | $19.9M | -$132.0M | -$95.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $17.1M | $20.6M | $1.4M | $5.5M |
| Temporary Equity Carrying Amount Attributable To Parent | $86.8M | $91.5M | $91.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.5M | -$4.2M | ||
| Retained Earnings Accumulated Deficit | -$95.6M | -$70.6M | -$133.6M | |
| Liabilities | $30.9M | $28.5M | $47.4M | |
| Liabilities And Stockholders Equity | $43.3M | $48.4M | $6.8M | |
| Common Stock Value | $2.0K | $2.0K | $1.0K | |
| Inventory Write Down | $25.0K | |||
| Property Plant And Equipment Net | $1.5M | $2.0M | $1.5M | |
| Other Assets Noncurrent | $3.0K | $14.0K | $23.0K | |
| Other Assets Current | $316.0K | $222.0K | $177.0K | |
| Operating Lease Right Of Use Asset | $697.0K | $188.0K | $130.0K | |
| Operating Lease Liability Noncurrent | $563.0K | $46.0K | $52.0K | |
| Operating Lease Liability Current | $155.0K | $143.0K | $79.0K | |
| Operating Lease Expense | $159.0K | |||
| Liabilities Current | $8.2M | $7.8M | $47.2M | |
| Inventory Net | $1.7M | $2.6M | $3.3M | |
| Intangible Assets Net Excluding Goodwill | $7.0M | $7.0M | $0.00 | |
| Goodwill | $14.0M | $14.0M | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $17.1M | $20.6M | $1.4M | |
| Assets Current | $20.1M | $25.3M | $5.2M | |
| Assets | $43.3M | $48.4M | $6.8M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$99.0K | $1.0K | $17.0K | |
| Accrued Liabilities Current | $7.0M | $3.7M | $3.0M | |
| Accounts Payable Current | $1.1M | $2.8M | $3.8M | |
| Other Liabilities Noncurrent | $3.6M | $8.0K | ||
| Accounts Receivable Net Current | $35.0K | $71.0K | ||
| Repayments Of Secured Debt | $1.1M | |||
| Gain Loss On Sale Of Property Plant Equipment | -$3.0K | |||
| Amortization Of Debt Discount Premium | $16.0K | |||
| Accrued Other Liabilities Current | $1.1M | $1.6M | ||
| Derivative Liabilities Noncurrent | $132.0K | $152.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.3M | $8.7M | $12.4M | $76.6M | -$140.5M | -$139.2M | -$123.5M | -$112.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.7M | $8.2M | $13.0M | $28.3M | $2.0M | $4.1M | $2.0M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $91.5M | $86.8M | $86.8M | $91.5M | $91.5M | $91.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.6M | -$6.9M | $2.7M | ||||||
| Retained Earnings Accumulated Deficit | -$92.3M | -$82.2M | -$78.3M | -$13.2M | -$2.1M | ||||
| Liabilities | $32.9M | $27.2M | $28.9M | $30.6M | $5.0K | ||||
| Liabilities And Stockholders Equity | $31.5M | $35.9M | $41.3M | $107.2M | |||||
| Common Stock Value | $2.0K | $2.0K | $2.0K | $1.0K | |||||
| Inventory Write Down | -$15.0K | $82.0K | |||||||
| Property Plant And Equipment Net | $1.7M | $1.9M | $2.1M | $1.6M | |||||
| Other Assets Noncurrent | $6.0K | $9.0K | $11.0K | $16.0K | |||||
| Other Assets Current | $811.0K | $1.1M | $507.0K | $213.0K | |||||
| Operating Lease Right Of Use Asset | $760.0K | $822.0K | $925.0K | $226.0K | |||||
| Operating Lease Liability Noncurrent | $596.0K | $629.0K | $668.0K | $85.0K | |||||
| Operating Lease Liability Current | $180.0K | $205.0K | $263.0K | $142.0K | |||||
| Operating Lease Expense | $22.0K | ||||||||
| Liabilities Current | $9.7M | $4.9M | $6.0M | $7.9M | |||||
| Inventory Net | $1.5M | $1.8M | $2.3M | $4.1M | |||||
| Intangible Assets Net Excluding Goodwill | $7.0M | $7.0M | $7.0M | $26.1M | |||||
| Goodwill | $14.0M | $14.0M | $14.0M | $44.3M | |||||
| Cash And Cash Equivalents At Carrying Value | $4.7M | $8.2M | $13.0M | $28.3M | |||||
| Assets Current | $8.1M | $12.2M | $17.4M | $35.0M | |||||
| Assets | $31.5M | $35.9M | $41.3M | $107.2M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$95.0K | -$99.0K | -$60.0K | -$9.0K | |||||
| Accrued Liabilities Current | $8.5M | $3.4M | $3.1M | $2.9M | |||||
| Accounts Payable Current | $1.0M | $1.3M | $2.6M | $4.4M | |||||
| Other Liabilities Noncurrent | $3.6M | $3.6M | $3.6M | ||||||
| Accounts Receivable Net Current | $1.0K | $90.0K | |||||||
| Repayments Of Secured Debt | $429.0K | ||||||||
| Gain Loss On Sale Of Property Plant Equipment | |||||||||
| Amortization Of Debt Discount Premium | $5.0K | ||||||||
| Accrued Other Liabilities Current | $448.0K | ||||||||
| Derivative Liabilities Noncurrent | $486.0K | $255.0K | $114.0K | $2.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2023 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$19.0M | -$25.7M |
| Increase Decrease In Accrued Liabilities | $3.3M | $886.0K |
| Payments To Acquire Property Plant And Equipment | $374.0K | $333.0K |
| Net Cash Provided By Used In Investing Activities | -$374.0K | -$340.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$867.0K | -$410.0K |
| Increase Decrease In Other Accrued Liabilities Current | $2.9M | $1.4M |
| Increase Decrease In Inventories | -$931.0K | $3.0M |
| Increase Decrease In Accounts Receivable | -$38.0K | $70.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$227.0K | -$47.0K |
| Depreciation Depletion And Amortization | $970.0K | $532.0K |
| Increase Decrease In Operating Lease Liability | $20.0K | -$161.0K |
| Increase Decrease In Accounts Payable | -$1.8M | $2.8M |
| Share Based Compensation | $1.5M | $442.0K |
| Increase Decrease In Accrued Transaction Costs Current | $444.0K | |
| Net Cash Provided By Used In Financing Activities | $16.1M | $21.9M |
| Proceeds From Notes Payable | $20.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q1 2024 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$7.2M | -$6.4M | -$6.7M |
| Increase Decrease In Accrued Liabilities | -$577.0K | -$651.0K | $678.0K |
| Payments To Acquire Property Plant And Equipment | $335.0K | $578.0K | $162.0K |
| Net Cash Provided By Used In Investing Activities | -$335.0K | -$578.0K | -$162.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$63.0K | $1.3M | -$90.0K |
| Increase Decrease In Other Accrued Liabilities Current | $658.0K | $344.0K | $706.0K |
| Increase Decrease In Inventories | -$256.0K | $130.0K | $281.0K |
| Increase Decrease In Accounts Receivable | -$34.0K | -$15.0K | -$70.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$77.0K | $42.0K | $30.0K |
| Depreciation Depletion And Amortization | $271.0K | $316.0K | $330.0K |
| Increase Decrease In Operating Lease Liability | -$22.0K | -$43.0K | |
| Increase Decrease In Accounts Payable | -$193.0K | -$356.0K | $884.0K |
| Share Based Compensation | $218.0K | $110.0K | |
| Increase Decrease In Accrued Transaction Costs Current | $199.0K | ||
| Net Cash Provided By Used In Financing Activities | $9.6M | ||
| Proceeds From Notes Payable | $10.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Earnings Per Share Diluted | $-1.51 | $-48.16 | ||
| Earnings Per Share Basic | $-1.51 | $-48.16 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 16.6M | |||
| Temporary Equity Shares Issued | 4.7M | 4.9M | 4.9M | |
| Common Stock Shares Authorized | 210.0M | 210.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 16.6M | |||
| Common Stock Shares Issued | 22.2M | 15.2M | ||
| Common Stock Shares Outstanding | 22.2M | 15.2M | ||
| Temporary Equity Shares Authorized | 4.9M | 4.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-0.66 | $-0.35 | $-0.51 | $0.02 | $-7.35 | $-10.28 | $-14.15 | |||
| Earnings Per Share Basic | $-0.66 | $-0.26 | $-0.50 | $-8.34 | $-7.35 | $-10.28 | $-14.15 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 15.4M | 15.4M | 15.4M | 16.1M | 779.9K | |||||
| Temporary Equity Shares Issued | 4.7M | 4.9M | 4.9M | 4.9M | ||||||
| Common Stock Shares Authorized | 210.0M | 210.0M | 210.0M | 210.0M | 6.6M | 6.6M | 6.6M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 15.4M | 15.4M | 15.4M | 987.8K | 779.9K | 779.9K | ||||
| Common Stock Shares Issued | 15.4M | 15.4M | 15.4M | 14.5M | 1.00 | 786.5K | ||||
| Common Stock Shares Outstanding | 15.4M | 15.4M | 15.4M | 14.5M | 779.9K | |||||
| Temporary Equity Shares Authorized | 4.9M | 4.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$20.0K | $42.0K | |
| Fair Value Adjustment Of Convertible Notes | $980.0K | $6.9M | |
| Costs And Expenses | $21.9M | $28.2M | |
| Investment Income Interest | $477.0K | $3.0K | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.5M | $442.0K | |
| Additional Paid In Capital | $108.1M | $90.5M | $1.6M |
| Stock Issued During Period Value Stock Options Exercised | $13.0K | ||
| Prepaid Expense Current | $989.0K | $1.9M | $232.0K |
| Interest Paid Net | $208.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $231.0K | $141.0K | -$38.0K | -$5.0M | -$94.0K | $80.0K | $23.0K |
| Fair Value Adjustment Of Convertible Notes | $3.5M | -$1.4M | -$190.0K | -$3.3M | -$1.6M | -$1.7M | $1.1M |
| Costs And Expenses | $5.7M | $4.7M | $7.4M | $4.6M | $6.9M | $8.8M | $9.1M |
| Investment Income Interest | $79.0K | $102.0K | $164.0K | $166.0K | $2.0K | $1.0K | $2.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $137.0K | $234.0K | $218.0K | $421.0K | $111.0K | $110.0K | $125.0K |
| Additional Paid In Capital | $91.1M | $90.9M | $90.7M | $89.8M | $2.1M | ||
| Stock Issued During Period Value Stock Options Exercised | $7.0K | $1.0K | $1.0K | $1.0K | |||
| Prepaid Expense Current | $1.1M | $1.1M | $1.6M | $2.3M | |||
| Interest Paid Net | $43.0K |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.